Table 3.

Participants with a ≥ 4-fold Rise in Serum Neutralizing Antibody Titers, by Study Group.

	Treatment Arm				p value1
	fIPV (n = 10)		fIPV + dmLT (n = 19)
	<4-fold rise	≥4-fold rise	<4-fold rise	≥4-fold rise
PV1 (n,%)	2 (20)	8 (80)	0	19 (100)	0.111
PV2 (n,%)	3 (30)	7 (70)	1 (5.3)	18 (94.7)	0.105
PV3 (n,%)	4 (40)	6 (60)	2 (10.5)	17 (89.5)	0.143
All (n,%)	5 (50)	5 (50)	3 (15.8)	16 (84.2)	0.083

¹2-sided Fisher Exact test.